Finance

NewTimeSpace News: SSY GROUP (02005.HK) announced that Baloxavir Marboxil active pharmaceutical ingredient (API) of the Group has been approved and registered by NMPA for use in marketed formulations, making the Company the third domestic enterprise to obtain the approval. Baloxavir Marboxil is mainly indicated for the treatment of influenza A and B viruses.

NewTimeSpace · 2026-07-13

NewTimeSpace (newtimespace.com) News, On July 13, 2026, Hong Kong large model concept stocks diverged in morning trading, with stocks such as Zhipu (2513.HK), Mininglamp Technology (2718.HK), and Kuaishou (1024.HK) leading the gains.As of 09:48, Zhipu (2513.HK) was quoted at HK$1,833.000, achieving an intraday surge of 11.77% and leading the gains in the large model concept stock theme.

NewTimeSpace · 2026-07-13

NewTimeSpace News: ABBISKO-B (02256.HK) announced on 13 July that ABSK211, an oral pan-KRAS inhibitor, has obtained FDA clearance for Phase I clinical development in advanced solid tumours with KRAS alterations. Preclinical data demonstrate broad potency against multiple KRAS variants and synergistic anti-tumour efficacy in combination regimens. The candidate has secured IND approvals in both China and the U.S. The Company reminds investors of uncertainties in drug development and approval processes.

NewTimeSpace · 2026-07-13

NewTimeSpace News: Longbio-B (01779.HK) announced on 13 July that LP-003, an in-house developed anti-IgE antibody, has obtained clearance from the U.S. FDA to launch clinical trials for peanut allergy. The global food allergy patient population is projected to reach 457 million by 2030. In China, the Company has secured IND approvals or initiated clinical studies of LP-003 across multiple allergic indications. The Company cautions uncertainties exist regarding successful development and commercialisation of the asset.

NewTimeSpace · 2026-07-13

NewTimeSpace News: INSILICO (03696.HK) announced on 13 July that the Group has entered into a new strategic cooperation for central nervous system drug research and development with Cosmo Pharmaceutical Holdings Limited. Leveraging INSILICO’s AI platform and Cosmo’s profound disease expertise, both parties will jointly advance innovative drug development. INSILICO is eligible to receive milestone payments of up to approximately RMB1.2 billion in aggregate, plus net sales royalties. The Company reminded investors that forward-looking statements are not guaranteed to materialise and shareholders should exercise caution when trading shares.

NewTimeSpace · 2026-07-13

NewTimeSpace News: GUOEN HOLDINGS (08121.HK) plans to conduct a rights issue on the basis of "1 for 4", with estimated net proceeds of HKD 40.4 million.

NewTimeSpace · 2026-07-13

NewTimeSpace News: DENOX ENV (01452.HK) plans to issue to shareholders in total 177.85 million shares by subscription, with estimated net proceeds of HKD 23.33 million.

NewTimeSpace · 2026-07-13

NewTimeSpace (newtimespace.com) News, GEEKPLUS-W(02590.HK) will spend HKD 11.57 million to repurchase 1.1 million shares on Jul 10, 2026.

NewTimeSpace · 2026-07-13

newtimespace.com reports, UBTECH Robotics received HKEX approval on 9 July 2026 for its H-share full circulation, involving the conversion of 5.4539 million domestic shares held by four shareholders into H shares. Upon completion, H shares will increase from 85.96% to 87.05% of total share capital, while domestic shares will decrease from 14.04% to 12.95%. The company must complete the relevant conversion procedures.

NewTimeSpace · 2026-07-13

newtimespace.com reports, BASiC Semiconductor will moderately adjust selling prices for certain products from Q3 2026, with increases of up to 25%, citing tight supply-demand balances driven by AI and new energy vehicle demand. The adjustment aims to support R&D investment and ensure supply stability, with implementation to be determined based on product category and order size.

NewTimeSpace · 2026-07-13

newtimespace.com reports, SouthGobi Resources’ largest shareholder JD Zhixing Fund has transferred US$19 million in payment-in-kind interest under convertible bonds to a transferee, with the payment date extended to 31 August 2027. The transferee intends to convert the interest into ordinary shares shortly, which based on current 50-day VWAP could result in the issuance of approximately 82.6 million shares, representing approximately 32.7% of existing share capital.

NewTimeSpace · 2026-07-13

YUM CHINA(09987.HK) will spend HKD 7.84 million to repurchase 23.25 thousand shares on Jul 10, 2026 .

NewTimeSpace · 2026-07-13

NewTimeSpace News: SERES Group Co., Ltd. (09927.HK) issued an H1 2026 profit warning. It expects a net loss attributable to listed parent shareholders ranging from RMB1.5 billion to RMB1.8 billion, compared with a profit of RMB2.941 billion in the same period last year, representing a swing from profit to loss. Core subsidiary AITO Automobile is projected to record a net loss of RMB1.05–1.3 billion.

NewTimeSpace · 2026-07-12

NewTimeSpace News: COASTAL GL (01124.HK) announced that a receiver has been appointed over 153,126,197 shares held by controlling shareholder Coastal International Holdings Limited (CIH), representing approximately 36.93% of issued share capital. The share charge relates to two financing agreements between CIH and lender Renwen Group, with aggregate outstanding liabilities exceeding HK$35 million.

NewTimeSpace · 2026-07-12

NewTimeSpace News: XUNCE (03317.HK) announced it has formally entered into a Memorandum of Understanding on strategic cooperation with Lutech S.p.A., a leading Italian digital and AI service provider. Both parties will jointly develop AI transformation solutions for the European market and advance commercial rollout of AI Token Factory across Europe. Lutech employs over 6,000 professionals with an annual business volume of approximately EUR 1 billion.

NewTimeSpace · 2026-07-12

NewTimeSpace News: XINXIN MINING (03833.HK) announced that it has received notification from its controlling shareholder Xinjiang Nonferrous Metal Industry (Group) Co., Ltd. regarding the proposed strategic restructuring between Xinjiang Nonferrous and Xinjiang Geological and Mineral Investment (Group) Co., Ltd. Up to now, the matter does not constitute a significant asset restructuring of the Company, will not trigger any change of controlling shareholder or ultimate controller, and will not materially disrupt the Company’s normal production and operation. The restructuring is subject to approval by competent authorities with uncertainties during implementation.

NewTimeSpace · 2026-07-12
Previous1..1617 181920..150     150 pages total